McNally R T, Brockbank K G
CryoLife Inc., Marietta, GA 30067.
J Med Eng Technol. 1992 Jan-Feb;16(1):34-8. doi: 10.3109/03091909209021955.
Allograft heart valves have been used for over 30 years. During the first decades of use, the research and clinical objectives were to find a means for long-term storage of tissue. Methods such as irradiation, glutaraldehyde fixation, long-term antibiotic storage at 4 degrees C and other methods were common. These methods, however, were found to give reduced long-term clinical performance when compared with viable fresh tissue or tissue which had been cryopreserved. Recognizing this fact, more recent emphasis has been to address issues surrounding means by which allografts can be cryopreserved and thawed to retain maximum viability. An additional concern was to find a means to maximize donor retrieval by salvaging tissue which normally would be discarded because of bacterial contamination. This study demonstrates that when a proper cryopreservation technique is used, with stringent antibiotic treatments, biomechanical parameters remain normal with only a slight decrease in cell viability.
同种异体心脏瓣膜已经使用了30多年。在最初使用的几十年里,研究和临床目标是找到一种组织长期保存的方法。诸如辐照、戊二醛固定、4℃长期抗生素保存等方法很常见。然而,与活的新鲜组织或冷冻保存的组织相比,这些方法被发现会降低长期临床性能。认识到这一事实后,最近的重点是解决围绕同种异体移植物如何冷冻保存和解冻以保持最大活力的问题。另一个关注点是找到一种方法,通过挽救通常因细菌污染而被丢弃的组织来最大限度地提高供体利用率。这项研究表明,当使用适当的冷冻保存技术并进行严格的抗生素治疗时,生物力学参数保持正常,细胞活力仅略有下降。